Search Within

Luis Felipe Ingrassia Campesato

Formats
  1. Meeting Abstract (13)
  2. Journal Article (8)
  3. Review (2)
  4. Editorial (1)
Groups
  1. Sloan Kettering Institute Postdocs (24)
  2. Department of Medicine (23)
  3. Melanoma and Immunotherapeutics Service (23)
  4. Solid Tumor Oncology Division (23)
  5. GSK Faculty (20)
  6. Hematology-Oncology Fellows (8)

More Groups

People
  1. Taha Merghoub (23)
  2. Jedd Wolchok (19)
  3. Sadna Budhu (16)
  4. Cailian Liu (9)
  5. Roberta Zappasodi (9)
  6. Rachel Giese (8)

More People

Years
  1. 2022 (2)
  2. 2021 (3)
  3. 2020 (4)
  4. 2019 (4)
  5. 2018 (5)
  6. 2017 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (7)
  2. Cancer Research (4)
  3. Annals of Translational Medicine (2)
  4. Journal of Clinical Investigation (2)
  5. Journal of Immunology (2)
  6. Cancer Immunology Research (1)

More Publications

Publishers
  1. Biomed Central Ltd (7)
  2. American Association for Cancer Research (5)
  3. AME Publishing Company (2)
  4. American Society for Clinical Investigation (2)
  5. Nature Publishing Group (2)
  6. The American Association of Immunologists, Inc (2)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers
    Meeting Abstract

    Budhu, S.; Gupta, A.; Fitzgerald, K.; Giese, R.; Michel, A.; Holland, A.; Campesato, L. F.; Van Snick, J.; Uyttenhove, C.; Ritter, G.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer
    Journal Article

    Gupta, A.; Budhu, S.; Fitzgerald, K.; Giese, R.; Michel, A. O.; Holland, A.; Campesato, L. F.; van Snick, J.; Uyttenhove, C.; Ritter, G.; more...
    Communications Biology (2021)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to tumor-directed radiation therapy in a preclinical model of melanoma
    Journal Article

    Budhu, S.; Giese, R.; Gupta, A.; Fitzgerald, K.; Zappasodi, R.; Schad, S.; Hirschhorn, D.; Campesato, L. F.; De Henau, O.; Gigoux, M.; more...
    Cell Reports (2021)

    Fulltext@MSK | Save
  • Innate immune checkpoints for cancer immunotherapy: Expanding the scope of non T cell targets
    Editorial

    Campesato, L. F.; Weng, C. H.; Merghoub, T.
    Annals of Translational Medicine (2020)

    Fulltext@MSK | Save
  • Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
    Journal Article

    Campesato, L. F.; Budhu, S.; Tchaicha, J.; Weng, C. H.; Gigoux, M.; Cohen, I. J.; Redmond, D.; Mangarin, L.; Pourpe, S.; Liu, C.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Blockade of AHR activation by IDO/TDO-derived kynurenine restricts cancer immune suppression
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Gigoux, M.; Tchaicha, J.; Pourpe, S.; Liu, C.; Zamarin, D.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • iNOS regulates the therapeutic response of pancreatic cancer cells to radiotherapy
    Journal Article

    Pereira, P. M. R.; Edwards, K. J.; Mandleywala, K.; Carter, L. M.; Escorcia, F. E.; Campesato, L. F.; Cornejo, M.; Abma, L.; Mohsen, A. A.; Iacobuzio-Donahue, C. A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save